Business Relations Table - o4.fyi ()

Anmelden Gast|Guest
Beispiel: brt.php?search=wide&s=wide&p=adjective&o=wideness

Domain-Statistiken für "skyebioscience.com"

53
Business Relations
54
Eindeutige Domains
20
Gefundene Einträge
BR-Relations: 53
From Domain Role To Domain Path Aktionen
/author/skye-bioscience/
/breaking-news/skye-bioscience-licenses-halozymes-enhanze-drug-delivery-technology/
/news-releases/detail/45/nemus-bioscience-identifies-unique-cannabidiol-cbd-derivative-as-a-lead-candidate-in-its-neuropathy-related-pain-management-program
/news-releases/detail/49/nemus-bioscience-and-catalent-to-advance-nb1222-into-human-dosage-formulation-development
/news-releases/detail/50/nemus-bioscience-signs-development-agreement-with-nanomerics-to-advance-ocular-formulation-of-nb1111-for-the-treatment-of-glaucoma-using-proprietary-molecular-envelope-technology-met
/news-releases/detail/52/nemus-bioscience-announces-20-million-series-e-preferred-stock-financing
/news-releases/detail/54/nemus-bioscience-reports-prodrug-of-tetrahydrocannabinol-thc-issued-patent-coverage-in-canada-and-hong-kong
/news-releases/detail/62/nemus-bioscience-announces-presentation-of-cbd-analogue-therapeutic-data-related-to-neuropathic-pain-nb2111-and-ocular-diseases-nb2222-at-upcoming-scientific-meetings
/news-releases/detail/62/nemus-bioscience-announces-presentation-of-cbd-analogue-therapeutic-data-related-to-neuropathic-pain-nb2111-and-ocular-diseases-nb2222-at-upcoming-scientific-meetings
/news-releases/detail/37/nemus-bioscience-inc-to-attend-upcoming-investment-conferences
/news-releases/detail/42/nemus-bioscience-ceo-to-present-at-bio-ceo-investor-conference
/news-releases/detail/118/skye-bioscience-announces-special-virtual-investor-presentation
/news-releases/detail/135/skye-bioscience-to-present-at-ld-micro-invitational
/empowered-patient-podcast/
/news-releases/detail/29/nemus-bioscience-inc-to-attend-upcoming-investment-conferences
/news-releases/detail/29/nemus-bioscience-inc-to-attend-upcoming-investment-conferences
/news-releases/detail/29/nemus-bioscience-inc-to-attend-upcoming-investment-conferences
/news-releases/detail/29/nemus-bioscience-inc-to-attend-upcoming-investment-conferences
/news-releases/detail/32/nemus-bioscience-announces-5-million-series-b-financing
/news-releases/detail/154/skye-bioscience-retains-lexitas-pharma-services-as-cro-for-phase-2-trial-of-sbi-100-ophthalmic-emulsion